ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
FEMS Immunology and Medical Microbiology
Volume 44, Issue 1, 1 April 2005, Pages 17-23
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.femsim.2004.10.003    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2004 Federation of European Microbiological Societies Published by Elsevier B.V.

High relative content of lysophospholipids of Helicobacter pylori mediates increased risk for ulcer disease

Tone Tannaesa, Ida K. Bukholmb and Geir Bukholma, Corresponding Author Contact Information, E-mail The Corresponding Author

aInstitute of Clinical Epidemiology and Molecular Biology, University of Oslo, Oslo, Norway bDepartment of Surgery, University of Oslo, Akershus University Hospital, Nordbyhagen, N-1478 Lørenskog, Norway

Received 10 September 2004; 
revised 29 September 2004; 
accepted 7 October 2004. 
Available online 30 October 2004.

This article is not included in your organization's subscription. However, you may be able to access this article under your organization's agreement with Elsevier.

Abstract

Helicobacter pylori phospholipase A (OMPLA) degrades bacterial membrane phospholipids to lysophospholipids. High levels of lysophospholipids are associated with higher hemolytic activity, increased release of urease and vacA and better adherence to epithelial cells in vitro. The phospholipase A gene (pldA) displays phase variation due to a slippage in a homopolymeric tract. The aim of this study was to determine if the relative amount of lysophospholipids in the cell wall is associated with ulcer disease, and to further investigate the significance of pldA phase variation. H. pylori isolates of 40 patients were examined. The relative lysophospholipid content of each isolate was determined and the pldA gene was sequenced. The study indicated that H. pylori can regulate its OMPLA activity by phase variation in the pldA gene or by protein level regulation among phase variants in the pldA ‘ON’ status. We found a significant difference between the relative amount of lysophospholipids of the ulcer group and the non-ulcer group (p = 0.022). When the lysophospholipid/phospholipid ratios were compared with outcome, the OR for ulcer disease was 9.0 (95% CI 1.6–49.4; p = 0.014). Isolates with a high OMPLA activity are significantly associated with patients with ulcer disease.

Keywords: Helicobacter pylori; Outer membrane phospholipase A; Phospholipid; Duodenal and gastric ulcer

Article Outline

1. Introduction
2. Materials and methods
2.1. Patients
2.2. Bacterial strains and cultivation conditions
2.3. Lipid extraction and phospholipid quantification
2.4. DNA extraction and sequence determination
2.5. Study of the heterogeneity in homopolymeric tracts from single patients
2.6. Amplified fragment length polymorphism
2.7. Amplification of vacA, cagA and iceA by PCR
2.8. Statistical analyses
3. Results
3.1. LysoPE/PE ratio
3.2. Sequencing of the pldA gene
3.3. Study of the heterogeneity in homopolymeric tracts from single patients
4. AFLP
4.1. cagA, vacA and iceA genotyping
5. Discussion
References


 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.